David A. Nathanson

Internal Medicine

320 Lennon Lane
Walnut Creek, CA 94587

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 137 publications

Glutamatergic neuron-tumor synapses shape human glioblastoma cell states through radial glia plasticity.

Glutamatergic neuron-tumor synapses shape human glioblastoma cell states through radial glia plasticity.

Journal: bioRxiv : the preprint server for biology

Published: May 25, 2026

Predictable clonal hierarchies from restricted progenitors provide a framework for cell type-specific therapies in glioblastoma.

Predictable clonal hierarchies from restricted progenitors provide a framework for cell type-specific therapies in glioblastoma.

Journal: bioRxiv : the preprint server for biology

Published: May 13, 2026

Beyond Cell Cycle Control: CDKN2A Loss Orchestrates NAD + Metabolic Plasticity and NAMPT Inhibitor Sensitivity in Glioblastoma.

Beyond Cell Cycle Control: CDKN2A Loss Orchestrates NAD + Metabolic Plasticity and NAMPT Inhibitor Sensitivity in Glioblastoma.

Journal: bioRxiv : the preprint server for biology

Published: January 23, 2026

Exemplifying Excellence in Brain Cancer Research: A Conversation with Tim Cloughesy, David A. Nathanson, and Johannes Czernin.

Exemplifying Excellence in Brain Cancer Research: A Conversation with Tim Cloughesy, David A. Nathanson, and Johannes Czernin.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: December 19, 2025

Beyond cell cycle control: CDKN2A loss is associated with altered NAD+ metabolic states and increased sensitivity to NAMPT inhibition in glioblastoma.

Beyond cell cycle control: CDKN2A loss is associated with altered NAD+ metabolic states and increased sensitivity to NAMPT inhibition in glioblastoma.

Journal: Neuro-oncology advances

Published: December 09, 2025

Translational Theranostics in Glioblastoma: FAPI-46 as a Precision Medicine Tool.

Translational Theranostics in Glioblastoma: FAPI-46 as a Precision Medicine Tool.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: December 02, 2025

MGMT downregulation by CRISPR/Cas13 RNA-guided RNA targeting enhances glioma cell sensitivity to TMZ chemotherapy.

MGMT downregulation by CRISPR/Cas13 RNA-guided RNA targeting enhances glioma cell sensitivity to TMZ chemotherapy.

Journal: Journal of neuro-oncology

Published: November 01, 2025

BRD2 bromodomain-mediated regulation of cell state plasticity modulates therapy response in glioblastoma.

BRD2 bromodomain-mediated regulation of cell state plasticity modulates therapy response in glioblastoma.

Journal: Neuro-oncology

Published: July 21, 2025

A Human Tumor-Immune Organoid Model of Glioblastoma.

A Human Tumor-Immune Organoid Model of Glioblastoma.

Journal: bioRxiv : the preprint server for biology

Published: July 16, 2025

Human organoid tumor transplantation identifies functional glioblastoma-microenvironment communication mediated by PTPRZ1.

Human organoid tumor transplantation identifies functional glioblastoma-microenvironment communication mediated by PTPRZ1.

Journal: Cell reports

Published: July 11, 2025

A human tumor-immune organoid model of glioblastoma.

A human tumor-immune organoid model of glioblastoma.

Journal: Cell reports

Published: June 09, 2025

Impact of corticosteroid administration on contrast-enhancing volume and diffusion MRI in treatment naïve glioblastoma.

Impact of corticosteroid administration on contrast-enhancing volume and diffusion MRI in treatment naïve glioblastoma.

Journal: Neuro-oncology

Published: May 30, 2025

Showing 1-12 of 137

Last Updated: 09/26/2026